Nicola Mikulcik Ohrner

Corporate Officer/Principal bei FORMYCON AG

53 Jahre

Health Technology

Profil

Nicola Mikulcik Ohrner is currently holding three positions in the biotech industry.
He is the Chief Executive Officer of bioeq GmbH, a Director at Bioeq AG, and the Chief Business Officer at Formycon AG.

Aktive Positionen von Nicola Mikulcik Ohrner

Unternehmen	Position	Beginn
FORMYCON AG	Corporate Officer/Principal	01.06.2022
bioeq GmbH bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany.	Chief Executive Officer	-
Bioeq AG Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland.	Director/Board Member	-

Alle aktiven Positionen von Nicola Mikulcik Ohrner

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Nicola Mikulcik Ohrner im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
FORMYCON AG	Health Technology

Private Unternehmen	2
Bioeq AG Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland.	Health Technology
bioeq GmbH bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany.	Health Technology